Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.3 EUR | +4.64% | +6.76% | +21.67% |
05-02 | GSK knew about Zantac cancer risk, attorneys tell jury in first trial | RE |
05-02 | GSK : Buy rating from Deutsche Bank | ZD |
Official Publications
No official publication found
- Stock Market
- Equities
- GSK Stock
- GS71 Stock
- News GSK plc
- Official Publications